Go Symbol Lookup
Loading...

>> View AllResults for ""

 Enter multiple symbolsseparated by commas

 London quotes now available

By the Numbers

Here are Today's Winners on the Biotech Index

 Text Size  
Published: Thursday, 19 Apr 2012 | 2:27 PM ET
Kristen Scholer By:
Source: Ian Wilson
GlaxoSmithKline

Shares of Human Genome Sciences surged on Thursday, nearly doubling after the company rejected an unsolicited buyout bid worth $2.6 billion in cash from GlaxoSmithKline .

On the news, the NYSE Arca Biotech Index is having its best day since December 2010.

Among the best performing stocks in the index, Gilead Sciences stock rose after one of its drugs showed positive results from a key hepatitis-C study.

  Price   Change %Change
DNDN ---
GILD ---
INCY ---
SQNM ---


Below are some of the largest biotech deals announced (including bids and letters of intent) in the last six months.

bythenumbers.cnbc.com

 Print
Human Genome Sciences is one of the reasons the NYSE Arca Biotech Index is having its best day since December 2010.
  Price   Change %Change
GILD ---
GSK ---
HGSI ---
DNDN ---
SQNM ---
CERN ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters
Preview Comment

CNBC welcomes your contribution. Please respect our community and the integrity of its participants. CNBC reserves the right to moderate and approve your comment.

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            

                Edit Comment
            

            

                Submit Comment
            

        
         
    
  





	    

	

    

        
        

            

            

        

         



    


	

	

	



			

		


		    
    		Featured